Q32 Bio Inc. (QTTB) Cash from Financing Activities (2017 - 2026)

Q32 Bio has reported Cash from Financing Activities for 10 years, with the latest figure at $58.6 million in Q2 2026.

• On a quarterly basis, Cash from Financing Activities changed N/A year-over-year to $58.6 million in Q2 2026; TTM through Jun 2026 was $64.3 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$3.1 million, down 103.28% from the prior year.
• Cash from Financing Activities was $58.6 million for Q2 2026 at Q32 Bio, up from $8.8 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $99.3 million in Q1 2024, with the low at -$5.5 million in Q2 2024.
• Average Cash from Financing Activities over 5 years is $10.7 million, with a median of $124000.0 recorded in 2022.
• The largest YoY upside for Cash from Financing Activities was 662206.67% in 2024 against a maximum downside of 36913.33% in 2024.
• Over 5 years, Cash from Financing Activities stood at $32000.0 in 2022, then soared by 137.5% to $76000.0 in 2023, then soared by 317.11% to $317000.0 in 2024, then slumped by 592.74% to -$1.6 million in 2025, then jumped by 3851.22% to $58.6 million in 2026.
• The last three Cash from Financing Activities figures came in at $58.6 million (Q2 2026), $8.8 million (Q1 2026), and -$1.6 million (Q4 2025), per Business Quant data.